Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

Marissa Brittenham, the Chief Strategy Officer of Surgery Partners, Inc. (NASDAQ:SGRY), has recently sold shares in the company. According to a filing with the Securities and Exchange Commission, ...

Global private equity and venture capital transaction value totaled $35.28 billion in January, down slightly compared with ...

David T. Doherty, the Chief Financial Officer of Surgery Partners, Inc. (NASDAQ:SGRY), has recently sold a portion of his holdings in the company. According to a filing submitted to the Securities and ...

Specifically, it will enrol around 680 patients with this form of cancer who don't achieve a pathological complete response (pCR) after the neoadjuvant therapy phase and surgery, placing them at ...

Roche was joined in the financing by a long list of venture investors in the round, including the American Cancer Society’s BrightEdge Ventures, ARK Investments, Bain Capital Life Sciences ...

--(BUSINESS WIRE)--Bain Capital, a leading private investment firm ... We share a common vision with Milacron’s associates, customers, and other partners to continue building on Milacron’s more than ...

Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...

Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma ...